Neos Therapeutics, Inc. announced that it has appointed Juergen A. Martens, PhD, to the position of Chief Technology and Operations Officer. Dr. Martens most recently served as Chief Operating Officer of MannKind Corporation from January 2015 to March 2016, and as the company’s Corporate Vice President of Operations and Chief Technology Officer from 2005 to 2015. From 2000 to 2005 he was Vice President of Pharmaceutical Technology Development at Nektar Therapeutics. Previously, he held technical management positions at Aerojet Fine Chemicals and FMC Corporation. Dr. Martens also held a variety of management positions with increased managerial responsibility in R&D, plant management, and business process development at Lonza, in Switzerland and in the United States.